Meghan Lee

4.1k total citations
20 papers, 420 citations indexed

About

Meghan Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Meghan Lee has authored 20 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Infectious Diseases. Recurrent topics in Meghan Lee's work include Renal cell carcinoma treatment (3 papers), COVID-19 Clinical Research Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Meghan Lee is often cited by papers focused on Renal cell carcinoma treatment (3 papers), COVID-19 Clinical Research Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Meghan Lee collaborates with scholars based in United States, China and Germany. Meghan Lee's co-authors include Jonathan B. Yuval, Julio García‐Aguilar, Hannah M. Thompson, Sujata Patil, Floris S. Verheij, Leonard B. Saltz, Jin K. Kim, Meghan E. Sise, Harish Seethapathy and Ian A. Strohbehn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of the American Society of Nephrology.

In The Last Decade

Meghan Lee

17 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meghan Lee United States 11 300 188 89 42 38 20 420
Jianming Hu China 8 150 0.5× 92 0.5× 128 1.4× 34 0.8× 24 0.6× 13 354
Ishita Sen India 11 106 0.4× 79 0.4× 106 1.2× 27 0.6× 34 0.9× 27 311
Qingyong Xu China 5 247 0.8× 78 0.4× 72 0.8× 16 0.4× 9 0.2× 6 336
Abhijit Sunnapwar United States 10 96 0.3× 123 0.7× 111 1.2× 20 0.5× 10 0.3× 21 324
Robert Król Poland 11 52 0.2× 181 1.0× 143 1.6× 26 0.6× 20 0.5× 65 406
Lisa Y. Law United States 8 113 0.4× 55 0.3× 49 0.6× 17 0.4× 11 0.3× 21 279
Shehla Sheikh Canada 7 290 1.0× 78 0.4× 314 3.5× 31 0.7× 27 0.7× 15 456
M. González Martín Spain 9 117 0.4× 354 1.9× 104 1.2× 41 1.0× 10 0.3× 60 484
Alp Özkan Türkiye 9 147 0.5× 55 0.3× 191 2.1× 14 0.3× 11 0.3× 21 378
Rishendran Naidoo Australia 11 75 0.3× 132 0.7× 151 1.7× 58 1.4× 6 0.2× 28 347

Countries citing papers authored by Meghan Lee

Since Specialization
Citations

This map shows the geographic impact of Meghan Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Lee more than expected).

Fields of papers citing papers by Meghan Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Lee. The network helps show where Meghan Lee may publish in the future.

Co-authorship network of co-authors of Meghan Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan Lee. A scholar is included among the top collaborators of Meghan Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan Lee. Meghan Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lyu, Jun, Meghan Lee, Sachin J. Shah, et al.. (2025). Sarcopenia, Elevated Body Mass Index, and Platinum-Associated Adverse Events in Patients With Lung Cancer. Journal of the National Comprehensive Cancer Network. 23(9). 393–400.
2.
Strohbehn, Ian A., et al.. (2024). The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study. Open Forum Infectious Diseases. 12(1). ofae756–ofae756. 1 indexed citations
3.
4.
Lee, Meghan, et al.. (2023). Abstract 3460: Targeting the MIF-CD74 axis to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Cancer Research. 83(7_Supplement). 3460–3460. 1 indexed citations
5.
Wang, Qiyu, Ian A. Strohbehn, Sophia Zhao, et al.. (2022). Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma. Kidney International Reports. 7(11). 2517–2521. 2 indexed citations
6.
Mehrara, Babak J., Hyeung Ju Park, Raghu P. Kataru, et al.. (2021). Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema. Biology. 10(9). 934–934. 41 indexed citations
7.
Strohbehn, Ian A., Sophia Zhao, Harish Seethapathy, et al.. (2021). Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza. Kidney International Reports. 6(10). 2565–2574. 29 indexed citations
8.
Strohbehn, Ian A., et al.. (2021). Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease. Kidney360. 2(8). 1316–1325. 1 indexed citations
9.
Lee, Meghan, et al.. (2021). Chronic Kidney Disease in Cancer Survivors. Advances in Chronic Kidney Disease. 28(5). 469–476.e1. 8 indexed citations
10.
Vorstenbosch, Joshua, Colleen M. McCarthy, Meghana G. Shamsunder, et al.. (2021). Smooth versus Textured Implant Breast Reconstruction: Patient-Reported Outcomes and Complications. Plastic & Reconstructive Surgery. 148(5). 959–967. 15 indexed citations
11.
Lee, Meghan, Harish Seethapathy, Ian A. Strohbehn, et al.. (2021). Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study. Journal for ImmunoTherapy of Cancer. 9(4). e002292–e002292. 24 indexed citations
12.
13.
Lee, Meghan, Harish Seethapathy, Orhan Efe, et al.. (2020). Dabrafenib-Induced Acute Interstitial Nephritis (AIN) and AKI in Patients with Cancer. Journal of the American Society of Nephrology. 31(10S). 664–664.
14.
Lee, Meghan, Ian A. Strohbehn, Harish Seethapathy, et al.. (2020). Clinical Features of AKI in Patients Receiving Tisagenlecleucel (CAR-T Therapy). Journal of the American Society of Nephrology. 31(10S). 664–664.
15.
García‐Aguilar, Julio, Sujata Patil, Jin K. Kim, et al.. (2020). Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.. Journal of Clinical Oncology. 38(15_suppl). 4008–4008. 139 indexed citations
16.
Seethapathy, Harish, Sophia Zhao, Ian A. Strohbehn, et al.. (2020). Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors. Kidney International Reports. 5(10). 1700–1705. 43 indexed citations
17.
Seethapathy, Harish, Meghan Lee, Ian A. Strohbehn, et al.. (2020). Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib. Nephrology Dialysis Transplantation. 37(3). 507–514. 10 indexed citations
18.
Seethapathy, Harish, Donald F. Chute, Meghan Lee, et al.. (2020). Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors. Nephrology Dialysis Transplantation. 36(12). 2241–2247. 39 indexed citations
19.
Lee, Meghan, et al.. (2017). Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population. Journal of Clinical Virology. 91. 79–83. 15 indexed citations
20.
Cohen, Wess A., Claudia R. Albornoz, Peter G. Cordeiro, et al.. (2016). Health-Related Quality of Life following Reconstruction for Common Head and Neck Surgical Defects. Plastic & Reconstructive Surgery. 138(6). 1312–1320. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianming Hu Breakdown of academic impact, for papers by Ishita Sen Breakdown of academic impact, for papers by Qingyong Xu Breakdown of academic impact, for papers by Abhijit Sunnapwar Breakdown of academic impact, for papers by Robert Król Breakdown of academic impact, for papers by Lisa Y. Law Breakdown of academic impact, for papers by Shehla Sheikh Breakdown of academic impact, for papers by M. González Martín Breakdown of academic impact, for papers by Alp Özkan Breakdown of academic impact, for papers by Rishendran Naidoo
Rankless by CCL
2026